What is HTA?
Health Technology Assessment (HTA)
We support the medical and pharmaceutical industry in navigating the Health Technology Assessment (HTA) process with comprehensive, end-to-end research. Our services are aligned with the HTA Council’s requirements and include clinical, social, and economic evaluations. From evidence appraisal and economic modeling to budget impact and health system analyses, we provide tailored insights to inform decision-making and policy development.
Why Choose MetaHealth?
| Feature | MetaHealth | Other Providers |
|---|---|---|
| Global Expertise, Local Mastery | Yes | No |
| End to End, In House (No Outsourcing) | Yes | No |
| Rooted in Public Health Values | Yes | No |
| On Time, High Quality Delivery | Yes | Mixed or No |
| Full Access to Global Evidence (Paid Journals) | Yes | No |
| Stakeholder Vetted Outputs | Yes | No |
| Feature | MetaHealth | Other Providers |
|---|---|---|
| Global Expertise, Local Mastery | Yes | No |
| End to End, In House (No Outsourcing) | Yes | No |
| Rooted in Public Health Values | Yes | No |
| On Time, High Quality Delivery | Yes | Mixed or No |
| Full Access to Global Evidence (Paid Journals) | Yes | No |
| Stakeholder Vetted Outputs | Yes | No |
Pioneers in Philippine HTA
We are the country’s first consulting firm purpose-built for Health Technology Assessment. With a deep bench of expertise and a sharp focus on evidence-informed policy, we’ve partnered with the DOST HTA Division, global development funders, and leading pharmaceutical companies to advance the HTA agenda in the Philippines.
- Globally Trained, Regionally Grounded
Our team brings training from top institutions both locally and abroad, coupled with hands-on HTA experience across the Asia-Pacific region. We combine academic depth with real-world understanding of the regional policy and access environment. - Proven Expertise in HTA Topic Nominations and Nominator-Led Assessments
We’ve supported multiple successful topic nominations and nominator-led HTA assessments in inaugural —achieving a high success rate. From crafting compelling nominations to navigating full assessments, we deliver strategic, evidence-based support that drives access and policy impact.
HTA Experience
- Supported diverse stakeholders—including pharma, hospitals, societies, and patient groups—through the full HTA process.
- Delivered end-to-end assistance: topic nomination, protocol development, evidence generation, and stakeholder engagement.
- Aligned submissions with HTA Council priorities, templates, and methodological standards.
- Achieved a 100% success rate in the 2023 Nominator-Led Assessments, with all three supported technologies prioritized.
- Demonstrated deep expertise in the Philippine HTA framework, regulatory landscape, and decision-making processes.
- Provide ongoing strategic guidance on positioning, dossier development, and end-to-end HTA support.
Our Edge
- Comprehensive, End-to-End Support: From topic nomination to post-assessment engagement—we cover the entire HTA journey.
- Aligned with HTA Philippines Standards: All outputs are fully compliant with HTA Council requirements, templates, and timelines.
- Deeply Contextualized to the Philippine Setting: We apply a nuanced understanding of the local health system, policy environment, and population needs.
- Driven by Best-in-Class Methods and Evidence: We use globally recognized methodologies and the most current, relevant data to ensure scientific rigor and policy relevance.
Your Vision.
Our Science.
Co-Created Solutions.
We pair scientific rigor with professional project management to deliver results that matter—designed with you, not just for you. At every milestone, we work collaboratively to align with your goals, anticipate stakeholder expectations, and produce outputs that earn credibility with key opinion leaders and decision-makers. Your vision shapes the path; your success is our priority.
Partner with the Philippines’ First HTA & HEOR-Dedicated Consultancy
From topic nomination to full HTA execution, metaHealth delivers regulatory-compliant, evidence-driven, and locally grounded solutions that move the needle on access and policy.
Trusted by national agencies, global funders, and leading pharma.
